"Dreaming supertramp, way too early mate.... "
You see that statement sums up the asx biotech investor. "Way too early", but Kineta are not even in pre-clinical trials. So Kineta's deal is way, way, way too early!
Luckily it's what the pharma world thinks and not what asx investors think that counts
"Dreaming supertramp, way too early mate.... " You see that...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.9¢ | 3.8¢ | $134.8K | 3.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 1738258 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 494405 | 4 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
